Affimed N.V. is a biopharmaceutical company dedicated to developing innovative cancer immunotherapies. With a focus on harnessing the power of the immune system, Affimed is revolutionizing the treatment of cancer by targeting specific proteins involved in tumor growth and survival. Through its cutting-edge technology and strategic partnerships, the company is poised to make a significant impact in the fight against cancer.
